Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Annelotte M. Vonk"'
Autor:
Sacha Spelier, Eyleen de Poel, Georgia N. Ithakisiou, Sylvia W.F. Suen, Marne C. Hagemeijer, Danya Muilwijk, Annelotte M. Vonk, Jesse E. Brunsveld, Evelien Kruisselbrink, Cornelis K. van der Ent, Jeffrey M. Beekman
Publikováno v:
ERJ Open Research, Vol 9, Iss 1 (2023)
Background Cystic fibrosis (CF) is a rare hereditary disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Recent therapies enable effective restoration of CFTR function of the most common F508del CFTR mu
Externí odkaz:
https://doaj.org/article/b2fb8a6f7608451d90c0f47932df4a5b
Autor:
Peter van Mourik, Sabine Michel, Annelotte M. Vonk, Jeffrey M. Beekman, Cornelis K. van der Ent, on behalf of the HIT-CF consortium
Publikováno v:
Translational Medicine Communications, Vol 5, Iss 1, Pp 1-8 (2020)
Abstract Background Cystic fibrosis is a rare recessive monogenic disease caused by loss-of-function mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. Recently developed CFTR-modulators (i.e. drugs that rescue CFTR-fun
Externí odkaz:
https://doaj.org/article/97619aed8c814abdb648904ea175743d
Autor:
Annelotte M. Vonk, Peter van Mourik, Anabela S. Ramalho, Iris A.L. Silva, Marvin Statia, Evelien Kruisselbrink, Sylvia W.F. Suen, Johanna F. Dekkers, Frank P. Vleggaar, Roderick H.J. Houwen, Jasper Mullenders, Sylvia F. Boj, Robert Vries, Margarida D. Amaral, Kris de Boeck, Cornelis K. van der Ent, Jeffrey M. Beekman
Publikováno v:
STAR Protocols, Vol 1, Iss 1, Pp 100019- (2020)
Summary: This protocol describes the isolation, handling, culture of, and experiments with human colon stem cell organoids in the context of cystic fibrosis (CF). In human colon organoids, the function of cystic fibrosis transmembrane conductance reg
Externí odkaz:
https://doaj.org/article/fefd7bcad3ec46998e45178ebd7ffc13
Autor:
Gitte Berkers, Peter van Mourik, Annelotte M. Vonk, Evelien Kruisselbrink, Johanna F. Dekkers, Karin M. de Winter-de Groot, Hubertus G.M. Arets, Rozemarijn E.P. Marck-van der Wilt, Jasper S. Dijkema, Maaike M. Vanderschuren, Roderick H.J. Houwen, Harry G.M. Heijerman, Eduard A. van de Graaf, Sjoerd G. Elias, Christof J. Majoor, Gerard H. Koppelman, Jolt Roukema, Marleen Bakker, Hettie M. Janssens, Renske van der Meer, Robert G.J. Vries, Hans C. Clevers, Hugo R. de Jonge, Jeffrey M. Beekman, Cornelis K. van der Ent
Publikováno v:
Cell Reports, Vol 26, Iss 7, Pp 1701-1708.e3 (2019)
Summary: In vitro drug tests using patient-derived stem cell cultures offer opportunities to individually select efficacious treatments. Here, we provide a study that demonstrates that in vitro drug responses in rectal organoids from individual patie
Externí odkaz:
https://doaj.org/article/dc8d3a11cbb948418c73a2e8f5b11051
Autor:
Sacha Spelier, Eyleen de Poel, Georgia N. Ithakisiou, Sylvia W.F. Suen, Marne C. Hagemeijer, Danya Muilwijk, Annelotte M. Vonk, Jesse E. Brunsveld, Evelien Kruisselbrink, Cornelis K. van der Ent, Jeffrey M. Beekman
Publikováno v:
ERJ Open Research. 9:00495-2022
BackgroundCystic fibrosis (CF) is a rare hereditary disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Recent therapies enable effective restoration of CFTR function of the most common F508delCFTRmutat
Autor:
Liron Birimberg-Schwartz, Wan Ip, Claire Bartlett, Julie Avolio, Annelotte M Vonk, Tarini Gunawardena, Kai Du, Mohsen Esmaeili, Jeffrey M Beekman, Johanna Rommens, Lisa Strug, Christine E Bear, Theo J Moraes, Tanja Gonska
Publikováno v:
Life Science Alliance. 6:e202201857
Highly effective drugs modulating the defective protein encoded by the CFTR gene have revolutionized cystic fibrosis (CF) therapy. Preclinical drug-testing on human nasal epithelial (HNE) cell cultures and 3-dimensional human intestinal organoids (3D
Autor:
Marne C. Hagemeijer, Nikhil T. Awatade, Christian Tischer, Annelotte M. Vonk, Margarida D. Amaral, Jeffrey M. Beekman, Volker Hilsenstein, Iris A.L. Silva, Hugo M. Botelho
Publikováno v:
Bioinformatics. 36:5686-5694
MotivationThe forskolin-induced swelling (FIS) assay has become the preferential assay to predict the efficacy of approved and investigational CFTR-modulating drugs for individuals with cystic fibrosis (CF). Currently, no standardized quantification
Autor:
Peter van Mourik, Simon Y. Graeber, Stephanie Hirtz, Evelien Kruisselbrink, Jeffrey M. Beekman, Cornelis K. van der Ent, Annelotte M. Vonk, Marcus A. Mall
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 202:1589-1592
Autor:
Sjoerd G. Elias, Gitte Berkers, Harry G.M. Heijerman, Rozemarijn E.P. Marck – van der Wilt, Renske van der Meer, Margot Geerdink, E. Kruisselbrink, S. Michel, Cornelis K. van der Ent, Jeffrey M. Beekman, Hans Clevers, Karin de Winter-de Groot, Rob Vries, Johanna F. Dekkers, Frank P. Vleggaar, Annelotte M. Vonk
Publikováno v:
Journal of Cystic Fibrosis. Elsevier B.V.
Background CFTR function measurements in intestinal organoids may help to better characterise individual disease expression in F508del homozygous people. Our objective was to study correlations between CFTR function as measured with forskolin-induced
Autor:
Huili Hu, Ellen J. Wehrens, Koen C. Oost, Anne C. Rios, Annelotte M. Vonk, Jane E. Visvader, Hans Clevers, Johanna F. Dekkers, Paul R. Jamieson, Hendrikus C R Ariese, Maria Alieva, Jeffrey M. Beekman, Hugo J. Snippert, Gimano D. Amatngalim, Lianne M Wellens
Publikováno v:
Nature Protocols, 14(6), 1756-1771. Nature Publishing Group
In vitro 3D organoid systems have revolutionized the modeling of organ development and diseases in a dish. Fluorescence microscopy has contributed to the characterization of the cellular composition of organoids and demonstrated organoids' phenotypic